The New Future of US Telehealth: Lasting Impacts of COVID-19

Ilya Trakhtenberg

future of US telehealth

COVID-19 expands use of telehealth

telehealth use cases

telehealth software ecosystem

eliminating telehealth barriers

COVID-19 and telehealth use cases

increased utilization of telehealth

hospital systems increase telehealth usage

virtual care and asynchronous visits biggest increases

structural and behavioral changes increase telehealth usage

patient and provider forced trial increase telehealth

waived regulatory and reimbursement restrictions with telehealth

forced trial to be lasting impact of COVID-19

telehealth expansion positive impacts and potential risks

telehealth evolution market

telehealth impact to payers and stakeholders

amazon and telehealth

For more information, please visit L.E.K.’s COVID-19 Insights Center or fill out this form to get in touch with us.

Related Insights

Life Sciences & Pharma

Presentations

European Disease Progression Monitor: Edition 5

April 28, 2020

Each week we will update our staff and clients with metrics to track disease progression

Life Sciences & Pharma

Published Articles

How to Approach an Increasingly Challenging and Subjective Japanese Pricing Environment

October 8, 2020

Japan remains on balance an attractive pharmaceutical market, with favorable volume dynamics, generally attractive pricing and broad and unfettered market…

Life Sciences & Pharma

Executive Insights

COVID-19 and Clinical Trials: Accelerating the Adoption of eClinical Technology

April 2, 2020

Interruptions to trial timelines are occurring with increasing frequency as sponsors and investigator sites feel the effects of the COVID-19 outbreak.

Life Sciences & Pharma

Published Articles

After a faltering start, Japan’s biosimilars marketplace appears on the cusp of rapid…

June 17, 2020

After a faltering start, Japan’s biosimilars marketplace appears on the cusp of rapid growth.

Life Sciences & Pharma

Executive Insights

Biopharma Launch Trends — Lessons Learned From L.E.K.’s Launch Monitor

December 18, 2020

The cost of drug development continues to rise and the probability of creating new blockbuster therapies is not getting any easier.

Organization & Performance

Presentations

Working from Home after COVID

July 21, 2020

COVID-19 is shaping a ‘new normal’ in working from home (WFH) that is expected to persist in the long term. L.E.K. researched how working patterns have…